Florian Glaser

Universität Witten/Herdecke, Witten, North Rhine-Westphalia, Germany

Are you Florian Glaser?

Claim your profile

Publications (1)1.85 Total impact

  • [Show abstract] [Hide abstract]
    ABSTRACT: Dysgerminomas comprise approximately 2-5% of all ovarian malignancies and mostly affect young adolescent women. Primary comprehensive surgery and adjuvant chemotherapy consisting of bleomycin, etoposide, and cisplatin (BEP) are the current recommended treatment options, the latter reserved for advanced stages (FIGO II-IV). We report two patients aged 20 and 26 years who presented with an initial FIGO stage IA, but inadequately assessed. Both were subsequently diagnosed with recurrent malignant dysgerminoma and para-aortic lymph node metastasis. Neither had received comprehensive staging at initial surgery nor adjuvant radio or chemotherapy. Both needed extensive surgery and multiagent chemotherapy for survival and belong to the small percentage of FIGO IA dysgerminoma patients showing a relapse. Comprehensive initial surgery including systematic para-aortic lymphadenectomy and adjuvant chemotherapy at tertiary referral centers is needed to minimize the treatment burden.
    Acta Obstetricia Et Gynecologica Scandinavica 01/2009; 88(11):1288-90. · 1.85 Impact Factor